This activity is supported by an educational grant from Lilly.

Meet the Faculty:

Richard K. Bogan MD, FCCP, FAASM 
Associate Clinical Professor 
University of South Carolina School of Medicine 
Principal, Bogan Sleep Consultants, LLC 
Columbia, SC 

April 8, 2025:

Abstracts:

Self-Reported Cognitive Complaints and Work Productivity in Participants With Narcolepsy or Idiopathic Hypersomnia After Low-Sodium Oxybate Treatment: Results From the Phase 4 DUET Study
 
The Orexin 2 Receptor Agonist ALKS 2680 in Patients with Narcolepsy Type 1: An Initial Proof of Concept Phase 1b Study
 
CRESCENDO: Results from a Survey of Symptom Burden and Quality of Life in Patients with Narcolepsy Type 1
 
Patient Preferences of Sodium Oxybate Treatment for Narcolepsy: RESTORE End-of-Study Survey Data
 
Development of a Novel Patient-reported Outcome Measure of Functional Impacts for Narcolepsy Types 1 and 2
 
Effectiveness and Safety of Low-Sodium Oxybate in Participants With Narcolepsy or Idiopathic Hypersomnia: Top-line Results From the Phase 4 DUET Study